selected publications
- Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the US. JAMA network open. 2020 Academic Article GET IT
- Active Surveillance for Men with Intermediate Risk Prostate Cancer. The Journal of urology. 2020 Academic Article GET IT
-
Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy.
Nature reviews. Clinical oncology.
2020
Comment
GET IT
Times cited: 18 - Challenging the Norm: What Level of Evidence Is Necessary to Adopt Postprostatectomy Hypofractionated Radiation Therapy?. International journal of radiation oncology, biology, physics. 2020 Editorial Article GET IT
-
Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States.
JAMA network open.
2020
Academic Article
GET IT
Times cited: 9 -
Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.
Breast cancer research : BCR.
2018
Academic Article
GET IT
Times cited: 3 -
Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?.
Clinical breast cancer.
2018
Academic Article
GET IT
Times cited: 15 -
The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
Clinical breast cancer.
2017
Academic Article
GET IT
Times cited: 8 -
Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
American journal of clinical oncology.
2017
Academic Article
GET IT
Times cited: 6 -
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.
Transplantation.
2017
Academic Article
GET IT
Times cited: 9 -
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2016
Academic Article
GET IT
Times cited: 22 -
Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
American journal of clinical oncology.
2016
Academic Article
GET IT
Times cited: 11 -
Disease-free survival according to the use of postmastectomy radiation therapy after neoadjuvant chemotherapy.
Clinical breast cancer.
2014
Academic Article
GET IT
Times cited: 9 -
Impact of oncotype DX recurrence score in the management of breast cancer cases.
Clinical breast cancer.
2013
Academic Article
GET IT
Times cited: 13 -
Administration of concurrent vaginal brachytherapy during chemotherapy for treatment of endometrial cancer.
International journal of radiation oncology, biology, physics.
2013
Academic Article
GET IT
Times cited: 6 -
Is there a tradeoff in using modified high tangent field radiation for treating an undissected node-positive axilla?.
Clinical breast cancer.
2013
Academic Article
GET IT
Times cited: 5 -
Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.
International journal of radiation oncology, biology, physics.
2011
Academic Article
GET IT
Times cited: 42 -
Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts.
The Journal of pathology.
2005
Academic Article
GET IT
Times cited: 66